Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The retinal photoreceptor cell apoptosis pathway refers to the set of molecular mechanisms driving programmed cell death of photoreceptors in the retina, a major cause of vision loss in retinal degenerative diseases. Key features include both caspase-dependent and caspase-independent processes, involving mitochondria (AIF, cytochrome c), endoplasmic reticulum (caspase-12), calcium-mediated calpain activation, and stress-responsive transcription factors such as c-Fos/AP-1. Disturbances such as genetic mutations, light-induced oxidative stress, or retinal detachment can trigger these processes. Modulation of these pathways represents a therapeutic approach to slow vision loss, but robust, single-target interventions have proven challenging due to pathway complexity and redundancy
Inhibition of caspase activation Inhibition of calpain activity Modulation of intracellular calcium signaling Blockade of apoptotic mediator nuclear translocation (e.g., AIF, caspase-12)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal photoreceptor cell apoptosis pathway.